Christopher M. Jewell

Christopher M. Jewell serves as the Chief Scientific Officer at Cartesian Therapeutics since January 2023 and has been a professor at the University of Maryland since August 2012, holding several prestigious titles including Robert E. Fischell Institute Professor of Translational Engineering. Jewell's expertise lies in advanced technologies and materials for generating immune responses and developing therapeutic vaccines. Jewish has consulted in biotechnology and pharmaceutical industries, engaging in due diligence and innovation strategy for immunotherapies and vaccines. Additionally, Jewell holds research positions with the United States Department of Veterans Affairs and has chaired scientific advisory boards for Vaccitech and Avidea Technologies. Jewell's educational background includes advanced degrees from the Massachusetts Institute of Technology and the University of Wisconsin-Madison, complemented by postdoctoral work at renowned institutions such as Harvard University.